The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations-Reference-Cited by-同舟云学术

The clinical spectrum of adult acute myeloid leukaemia associated with core binding factor translocations

Published:2006-10 Issue:2 Volume:135 Page:165-173
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Appelbaum Frederick R.,Kopecky Kenneth J.,Tallman Martin S.,Slovak Marilyn L.,Gundacker Holly M.,Kim Haesook T.,Dewald Gordon W.,Kantarjian Hagop M.,Pierce Sherry R.,Estey Elihu H.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2006.06276.x/fullpdf

Reference32 articles.

1. Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

2. Age and acute myeloid leukemia

3. Patients With t(8;21)(q22;q22) and Acute Myeloid Leukemia Have Superior Failure-Free and Overall Survival When Repetitive Cycles of High-Dose Cytarabine Are Administered

4. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

5. Repetitive Cycles of High-Dose Cytarabine Benefit Patients With Acute Myeloid Leukemia and inv(16)(p13q22) or t(16;16)(p13;q22): Results from CALGB 8461

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia;Leukemia Research;2024-10

2. Trends in allogeneic transplantation for favorable risk acute myeloid leukemia in first remission: a longitudinal study of >15 years from the ALWP of the EBMT;Bone Marrow Transplantation;2024-08-20

3. Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT;Bone Marrow Transplantation;2024-08-02

4. Neratinib impairs function of m6A recognition on AML1-ETO pre-mRNA and induces differentiation of t (8;21) AML cells by targeting HNRNPA3;Cancer Letters;2024-07

5. Characteristics and outcomes of acute myeloid leukaemia patients with baseline CD7 expression;British Journal of Haematology;2024-04-11